<?xml version="1.0" encoding="UTF-8"?>
<patent-document ucid="EP-2682072-A1" country="EP" doc-number="2682072" kind="A1" date="20140108" family-id="41720600" file-reference-id="311895" date-produced="20180822" status="corrected" lang="EN"><bibliographic-data><publication-reference fvid="146585535" ucid="EP-2682072-A1"><document-id><country>EP</country><doc-number>2682072</doc-number><kind>A1</kind><date>20140108</date><lang>EN</lang></document-id></publication-reference><application-reference ucid="EP-13186165-A" is-representative="NO"><document-id mxw-id="PAPP154847727" load-source="docdb" format="epo"><country>EP</country><doc-number>13186165</doc-number><kind>A</kind><date>20091216</date><lang>EN</lang></document-id><document-id mxw-id="PAPP226229765" load-source="docdb" format="original"><country>EP</country><doc-number>13186165.0</doc-number><date>20091216</date></document-id></application-reference><priority-claims><priority-claim mxw-id="PPC140554723" ucid="EP-09179414-A" linkage-type="3" load-source="docdb"><document-id format="epo"><country>EP</country><doc-number>09179414</doc-number><kind>A</kind><date>20091216</date></document-id></priority-claim><priority-claim mxw-id="PPC140555907" ucid="US-14049408-P" load-source="docdb"><document-id format="epo"><country>US</country><doc-number>14049408</doc-number><kind>P</kind><date>20081223</date></document-id></priority-claim></priority-claims><technical-data><classifications-ipcr><classification-ipcr mxw-id="PCL1989318838" load-source="docdb">A61F   2/24        20060101AFI20131202BHEP        </classification-ipcr></classifications-ipcr><classifications-cpc><classification-cpc mxw-id="PCL-1627944121" load-source="docdb" scheme="CPC">A61F2220/0075      20130101 LA20180609BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1627944122" load-source="docdb" scheme="CPC">A61F2220/0058      20130101 LA20180609BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1627944123" load-source="docdb" scheme="CPC">A61F2230/0054      20130101 LA20180609BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2133817636" load-source="docdb" scheme="CPC">A61F   2/2427      20130101 LI20141127BHEP        </classification-cpc><classification-cpc mxw-id="PCL2114901072" load-source="docdb" scheme="CPC">A61F   2/2436      20130101 LI20140917BHEP        </classification-cpc><classification-cpc mxw-id="PCL2114905550" load-source="docdb" scheme="CPC">A61F   2/2418      20130101 FI20140917BHEP        </classification-cpc></classifications-cpc><invention-title mxw-id="PT132361238" lang="DE" load-source="patent-office">Erweiterbare Klappenprothese mit Verankerungsfortsätzen</invention-title><invention-title mxw-id="PT132361239" lang="EN" load-source="patent-office">Expandable prosthetic valve having anchoring appendages</invention-title><invention-title mxw-id="PT132361240" lang="FR" load-source="patent-office">Soupape prothétique extensible dotée dýappendices dýancrage</invention-title><citations><patent-citations><patcit mxw-id="PCIT242944481" load-source="docdb" ucid="DE-10301026-A1"><document-id format="epo"><country>DE</country><doc-number>10301026</doc-number><kind>A1</kind><date>20040226</date></document-id><sources><source name="SEA" category="X" created-by-npl="N"/></sources></patcit><patcit mxw-id="PCIT242944482" load-source="docdb" ucid="EP-1570809-A1"><document-id format="epo"><country>EP</country><doc-number>1570809</doc-number><kind>A1</kind><date>20050907</date></document-id><sources><source name="APP" created-by-npl="N"/></sources></patcit><patcit mxw-id="PCIT377889042" load-source="docdb" ucid="EP-1690515-A1"><document-id format="epo"><country>EP</country><doc-number>1690515</doc-number><kind>A1</kind><date>20060816</date></document-id><sources><source name="APP" created-by-npl="N"/><source name="SEA" category="XDI" created-by-npl="N"/></sources></patcit><patcit mxw-id="PCIT242944487" load-source="docdb" ucid="EP-1935377-A1"><document-id format="epo"><country>EP</country><doc-number>1935377</doc-number><kind>A1</kind><date>20080625</date></document-id><sources><source name="APP" created-by-npl="N"/></sources></patcit><patcit mxw-id="PCIT242944486" load-source="docdb" ucid="EP-1935378-A1"><document-id format="epo"><country>EP</country><doc-number>1935378</doc-number><kind>A1</kind><date>20080625</date></document-id><sources><source name="APP" created-by-npl="N"/></sources></patcit><patcit mxw-id="PCIT242944488" load-source="docdb" ucid="EP-2014257-A1"><document-id format="epo"><country>EP</country><doc-number>2014257</doc-number><kind>A1</kind><date>20090114</date></document-id><sources><source name="APP" created-by-npl="N"/></sources></patcit><patcit mxw-id="PCIT242944491" load-source="docdb" ucid="EP-2033581-A1"><document-id format="epo"><country>EP</country><doc-number>2033581</doc-number><kind>A1</kind><date>20090311</date></document-id><sources><source name="APP" created-by-npl="N"/></sources></patcit><patcit mxw-id="PCIT242944490" load-source="docdb" ucid="EP-2033597-A1"><document-id format="epo"><country>EP</country><doc-number>2033597</doc-number><kind>A1</kind><date>20090311</date></document-id><sources><source name="APP" created-by-npl="N"/></sources></patcit><patcit mxw-id="PCIT377889043" load-source="docdb" ucid="EP-2047824-A1"><document-id format="epo"><country>EP</country><doc-number>2047824</doc-number><kind>A1</kind><date>20090415</date></document-id><sources><source name="APP" created-by-npl="N"/><source name="SEA" category="XDP" created-by-npl="N"/></sources></patcit><patcit mxw-id="PCIT377889044" load-source="docdb" ucid="EP-2119417-A2"><document-id format="epo"><country>EP</country><doc-number>2119417</doc-number><kind>A2</kind><date>20091118</date></document-id><sources><source name="APP" created-by-npl="N"/><source name="SEA" category="XDP" created-by-npl="N"/></sources></patcit><patcit mxw-id="PCIT242944485" load-source="docdb" ucid="US-5163954-A"><document-id format="epo"><country>US</country><doc-number>5163954</doc-number><kind>A</kind><date>19921117</date></document-id><sources><source name="APP" created-by-npl="N"/></sources></patcit><patcit mxw-id="PCIT242944489" load-source="docdb" ucid="WO-2009024716-A2"><document-id format="epo"><country>WO</country><doc-number>2009024716</doc-number><kind>A2</kind><date>20090226</date></document-id><sources><source name="SEA" category="XP" created-by-npl="N"/></sources></patcit><patcit mxw-id="PCIT242944494" load-source="docdb" ucid="WO-2009045331-A1"><document-id format="epo"><country>WO</country><doc-number>2009045331</doc-number><kind>A1</kind><date>20090409</date></document-id><sources><source name="SEA" category="XP" created-by-npl="N"/></sources></patcit><patcit mxw-id="PCIT242944495" load-source="docdb" ucid="WO-2009094188-A2"><document-id format="epo"><country>WO</country><doc-number>2009094188</doc-number><kind>A2</kind><date>20090730</date></document-id><sources><source name="SEA" category="XP" created-by-npl="N"/></sources></patcit></patent-citations></citations></technical-data><related-documents><relation type="division"><child-doc ucid="EP-13186165-A"><document-id load-source="patent-office" format="epo"><country>EP</country><doc-number>13186165</doc-number><kind>A</kind><date>20091216</date></document-id></child-doc><parent-doc ucid="EP-09179414.9"><document-id load-source="patent-office" format="epo"><country>EP</country><doc-number>09179414.9</doc-number><date>20091216</date></document-id><parent-grant-document ucid="EP-2201911-B1"><document-id><country>EP</country><doc-number>2201911</doc-number><kind>B1</kind><date>20150930</date></document-id></parent-grant-document></parent-doc></relation></related-documents><parties><applicants><applicant mxw-id="PPAR919525957" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>SORIN GROUP ITALIA SRL</last-name><address><country>IT</country></address></addressbook></applicant><applicant mxw-id="PPAR919545102" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>SORIN GROUP ITALIA S.R.L.</last-name></addressbook></applicant><applicant mxw-id="PPAR919016616" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>Sorin Group Italia S.r.l.</last-name><iid>101363565</iid><address><street>Via Crescentino sn</street><city>13040 SALUGGIA (VC)</city><country>IT</country></address></addressbook></applicant></applicants><inventors><inventor mxw-id="PPAR919504437" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>RIGHINI GIOVANNI</last-name><address><country>IT</country></address></addressbook></inventor><inventor mxw-id="PPAR919527663" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>RIGHINI, GIOVANNI</last-name></addressbook></inventor><inventor mxw-id="PPAR919019625" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>RIGHINI, GIOVANNI</last-name><address><street>Corso Galileo Ferraris, 51/N</street><city>10034 Chivasso (Torino)</city><country>IT</country></address></addressbook></inventor></inventors><agents><agent mxw-id="PPAR919015324" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>De Bonis, Paolo</last-name><iid>101409197</iid><address><street>Buzzi, Notaro &amp; Antonielli d'Oulx S.r.l. Via Maria Vittoria, 18</street><city>10123 Torino</city><country>IT</country></address></addressbook></agent></agents></parties><international-convention-data><designated-states><ep-contracting-states><country mxw-id="DS549824538" load-source="docdb">AT</country><country mxw-id="DS549826854" load-source="docdb">BE</country><country mxw-id="DS549752280" load-source="docdb">BG</country><country mxw-id="DS549910584" load-source="docdb">CH</country><country mxw-id="DS549821268" load-source="docdb">CY</country><country mxw-id="DS549824539" load-source="docdb">CZ</country><country mxw-id="DS549826855" load-source="docdb">DE</country><country mxw-id="DS549821269" load-source="docdb">DK</country><country mxw-id="DS549821274" load-source="docdb">EE</country><country mxw-id="DS549748777" load-source="docdb">ES</country><country mxw-id="DS549752289" load-source="docdb">FI</country><country mxw-id="DS549752290" load-source="docdb">FR</country><country mxw-id="DS549826856" load-source="docdb">GB</country><country mxw-id="DS549821275" load-source="docdb">GR</country><country mxw-id="DS549826857" load-source="docdb">HR</country><country mxw-id="DS549824540" load-source="docdb">HU</country><country mxw-id="DS549910585" load-source="docdb">IE</country><country mxw-id="DS549821276" load-source="docdb">IS</country><country mxw-id="DS549752291" load-source="docdb">IT</country><country mxw-id="DS549821277" load-source="docdb">LI</country><country mxw-id="DS549828357" load-source="docdb">LT</country><country mxw-id="DS549750174" load-source="docdb">LU</country><country mxw-id="DS549828362" load-source="docdb">LV</country><country mxw-id="DS549828363" load-source="docdb">MC</country><country mxw-id="DS549750175" load-source="docdb">MK</country><country mxw-id="DS549750176" load-source="docdb">MT</country><country mxw-id="DS549748778" load-source="docdb">NL</country><country mxw-id="DS549752292" load-source="docdb">NO</country><country mxw-id="DS549750181" load-source="docdb">PL</country><country mxw-id="DS549910586" load-source="docdb">PT</country><country mxw-id="DS549748779" load-source="docdb">RO</country><country mxw-id="DS549750182" load-source="docdb">SE</country><country mxw-id="DS549826862" load-source="docdb">SI</country><country mxw-id="DS549752313" load-source="docdb">SK</country><country mxw-id="DS549750183" load-source="docdb">SM</country><country mxw-id="DS549821282" load-source="docdb">TR</country></ep-contracting-states></designated-states></international-convention-data></bibliographic-data><abstract mxw-id="PA128673707" lang="EN" load-source="patent-office"><p id="pa01" num="0001">A heart valve prosthesis includes an expandable prosthetic valve (2) including three valve leaflets (24a, 24b, 24c) coupled to an anchoring structure (6). The anchoring structure includes an annular member and a plurality of arms (10) movably coupled to the annular member at one end. The free ends of the arms (10) extend radially away from the prosthesis toward a valve annulus. The arms (10) are configured to fit in a space defined between an open native valve leaflet and a wall of a valve sinus. The arms (10) are sufficiently resilient such that they resist downward movement in response to pressure exerted on the prosthesis, facilitating anchorage and stabilization of the prosthesis at the implantation site.
<img id="iaf01" file="imgaf001.tif" wi="89" he="99" img-content="drawing" img-format="tif"/></p></abstract><abstract mxw-id="PA128737866" lang="EN" source="EPO" load-source="docdb"><p>A heart valve prosthesis includes an expandable prosthetic valve (2) including three valve leaflets (24a, 24b, 24c) coupled to an anchoring structure (6). The anchoring structure includes an annular member and a plurality of arms (10) movably coupled to the annular member at one end. The free ends of the arms (10) extend radially away from the prosthesis toward a valve annulus. The arms (10) are configured to fit in a space defined between an open native valve leaflet and a wall of a valve sinus. The arms (10) are sufficiently resilient such that they resist downward movement in response to pressure exerted on the prosthesis, facilitating anchorage and stabilization of the prosthesis at the implantation site.</p></abstract><description mxw-id="PDES63959695" lang="EN" load-source="patent-office"><!-- EPO <DP n="1"> --><heading id="h0001">BACKGROUND</heading><p id="p0001" num="0001">The present invention relates to cardiac-valve prostheses. More specifically, the present invention is directed to a prosthesis amenable to a minimally-invasive implantation procedure having a stent-like anchoring structure. These prostheses (often referred to as percutaneous valves) typically include an anchoring structure, which is able to support and fix the valve prosthesis at the implantation site, and prosthetic valve elements, generally in the form of leaflets or flaps, which are connected to the anchoring structure and configured to regulate blood flow. The prosthetic valve may be introduced into a position corresponding to the natural annulus and deployed in situ by divaricating the native valve leaflets (or following removal of the native leaflets).</p><heading id="h0002">SUMMARY</heading><p id="p0002" num="0002">The present invention, according to one exemplary embodiment, is a valve prosthesis for implantation in or near a human heart at a valve site including one or more valve sinuses. The prosthesis includes an anchoring structure comprising an annular outflow member, an annular inflow member, and a plurality of arms each coupled at one end to the annular outflow member, the arms having a first end coupled to the annular outflow member and a second end configured to contact a base of the valve sinus. It further includes a plurality of leaflets coupled to the anchoring structure and adapted to substantially allow blood flow in a first direction and to substantially prevent blood flow in a second direction. The annular outflow member has an expanded position generally configured to engage a vessel wall at a location distal to the valve sinus, and at least one of the plurality of arms is shaped to engage substantially an entire longitudinally extending surface of the valve sinus.</p><p id="p0003" num="0003">According to another embodiment, the present invention is a valve prosthesis having an plurality of valve leaflets coupled to an anchoring structure. The anchoring structure includes one or more anchoring arms adapted to<!-- EPO <DP n="2"> --> substantially engage a valve sinus. The anchoring arms include a free end adapted to contact a base of the valve sinus adjacent one or more native valve leaflets.</p><p id="p0004" num="0004">The present invention, according to yet another embodiment, is a method of implanting an expandable valve prosthesis at a target implantation site in or near a patient's heart, the implantation site including at least one valve sinus. The method includes providing a heart valve prosthesis including a prosthetic valve having three leaflets coupled to an anchoring structure, the anchoring structure including an annular member coupled to a plurality of arms having first and second ends, such that the second ends are not directly coupled to the anchoring structure; transitioning the prosthesis from an expanded position to a collapsed position; delivering the prosthesis to a target implantation site within a patient's heart in a minimally invasive manner; facilitating expansion of the prosthesis including the arms; and positioning the second ends of the arms in a space defined between a native valve leaflet and a sinus wall.</p><p id="p0005" num="0005">According to a further embodiment, the present invention is a kit for implanting a heart valve prosthesis at an implantation site within a patient's heart. The kit includes an expandable heart valve prosthesis including an expandable prosthetic heart valve having three leaflets coupled to an anchoring structure, the anchoring structure including an annular outflow member and a plurality of arms movably coupled to the annular member, wherein the arms are configured to contact a base of a valve sinus adjacent an open native heart valve leaflet; a crimping tool adapted to transition the prosthesis from an expanded position to a collapsed position; and a delivery catheter adapted to deliver the prosthesis to the implantation site.</p><p id="p0006" num="0006">While multiple embodiments are disclosed, still other embodiments of the present invention will become apparent to those skilled in the art from the following detailed description, which shows and describes illustrative embodiments of the invention. Accordingly, the drawings and detailed description are to be regarded as illustrative in nature and not restrictive.<!-- EPO <DP n="3"> --></p><heading id="h0003">BRIEF DESCRIPTION OF THE DRAWINGS</heading><p id="p0007" num="0007"><figref idrefs="f0001">FIG. 1</figref> is a sectional view of an aorta of the human heart having an implanted expandable heart valve prosthesis according to an embodiment of the present invention implanted within or adjacent to an aortic valve.</p><p id="p0008" num="0008"><figref idrefs="f0001">Fig. 2</figref> is a top perspective view of an expandable prosthetic valve including an anchoring structure according to an embodiment of the present invention.</p><p id="p0009" num="0009"><figref idrefs="f0002">Fig. 3</figref> is a perspective view of an expandable prosthetic valve including an anchoring structure according to another embodiment of the present invention.</p><p id="p0010" num="0010"><figref idrefs="f0002">FIG. 4</figref> is a top, schematic view of an expandable prosthetic valve implanted at an implantation site according to an embodiment of the present invention.</p><p id="p0011" num="0011"><figref idrefs="f0003">FIG. 5</figref> is a flow chart of a method of implanting an expandable prosthetic heart valve according to various embodiments of the present invention.</p><p id="p0012" num="0012"><figref idrefs="f0004">FIG. 6</figref> is a schematic view of a delivery system for implanting an expandable prosthetic valve according to various embodiments of the present invention.</p><p id="p0013" num="0013">While the invention is amenable to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings and are described in detail below. The intention, however, is not to limit the invention to the particular embodiments described. On the contrary, the invention is intended to cover all modifications, equivalents, and alternatives falling within the scope of the invention as defined by the appended claims.</p><heading id="h0004">DETAILED DESCRIPTION</heading><p id="p0014" num="0014"><figref idrefs="f0001">FIG. 1</figref> shows a perspective view of an expandable prosthetic valve 2, according to an embodiment of the present invention. As shown in <figref idrefs="f0001">FIG. 1</figref>, the prosthetic valve 2 includes an anchoring structure 6 having anchoring arms or appendages 10. The prosthetic valve 2 is shown implanted within or adjacent an<!-- EPO <DP n="4"> --> aortic annulus 16 of an ascending aorta 18, which is coupled to the left ventricle of a heart. During normal operation, the left ventricle pumps blood out of the heart through the aortic annulus 16 and into the ascending aorta 18 (as indicated by the arrows in <figref idrefs="f0001">FIG. 1</figref>). The prosthetic heart valve 2 is suitable for implantation within or adjacent a valved intraluminal site using endovascular delivery techniques known to those of skill in the art. Such a site includes, for example, the aortic valve 16 (as shown in <figref idrefs="f0001">FIG. 1</figref>), the tricuspid valve, the pulmonary valve, and the mitral valve of a patient's heart. The prosthetic heart valve 2 is implanted within the valved intraluminal site such that the native valve leaflets 19 are held in the open position and the prosthetic heart valve 2 is expanded to bear against a vessel or sinus wall, e.g., the Valsalva sinus (VS). The prosthetic valve 2, includes an annular proximal (or inflow) ring 20 located at or near the native valve annulus and an annular distal (or outflow) ring 21 generally located at an opposite end of the valve (i.e., away from the valve annulus).</p><p id="p0015" num="0015"><figref idrefs="f0001">FIG. 2</figref> is a top perspective view of a prosthetic valve and <figref idrefs="f0002">FIG. 3</figref> is a side perspective view of a prosthetic valve according to various embodiments of the present invention. As shown in <figref idrefs="f0001">FIGS. 2</figref> and <figref idrefs="f0002">3</figref>, each of the expandable prosthetic valves 2 includes a valve sleeve 22 including three leaflets 24a, 24b, and 24c coupled to the anchoring structure 6. The valve sleeve 22 may be constructed according to various techniques known in the art. The valve sleeve 22 includes a base portion 30 with an overall annular pattern, designed to extend from the lower portion of the prosthetic valve 2, which at the implantation site, is in a position proximal to the valve annulus. Three pleat formations 32 extend distally from the base portion 30. The valve leaflets 24a, 24b and 24c extend between adjacent pleat formations 32. Each valve leaflet 24a, 24b and 24c has a proximal edge with an arched pattern that extends from the base formation 30 and along two adjacent pleat formations 32, and a distal edge that extends towards a central orifice of the prosthesis, so as to cooperate with the edges of the other valve leaflets in a coapting fashion.</p><p id="p0016" num="0016">As is generally known by those of ordinary skill in the art, in operation, as blood flows out of the ventricle and through the prosthetic valve 2,<!-- EPO <DP n="5"> --> the compliant valve leaflets 24a, 24b, 24c are adapted to deform and move towards the support structure 6 to allow free flow of the blood through the prosthesis. When the pressure gradient, and hence the direction of flow, of the blood through the prosthesis is reversed (i.e., blood is flowing into the left ventricle), the coapting edges of the valve leaflets 24a, 24b, 24c move towards each other (e.g., contact each other) such that the leaflets substantially close and thus prevent the flow of the blood through the prosthesis 2. In some embodiments of the present invention, the valve leaflets 24a, 24b, 24c are made in such a way as to assume, in the absence of external stresses, the closed configuration. In various embodiments, as shown in <figref idrefs="f0002">FIG. 3</figref> the valve sleeve 22 includes an annular securing device 36, located at or near a proximal end of the valve, for securing the prosthetic valve 2 to the valve annulus. According to some embodiments, the annular securing device 36 is a sewing ring such as that shown and described in <patcit id="pcit0001" dnum="US5163954A"><text>U.S. Patent 5,163,954</text></patcit>.</p><p id="p0017" num="0017">The anchoring structure 6 is adapted to stabilize and secure the prosthetic valve 2 at an implantation site within a patient's body. As shown in <figref idrefs="f0002">FIG. 3</figref>, the anchoring structure 6 includes an annular outflow member 52, a plurality of vertical support members 54, and at least three anchoring appendages or arms 10 coupled to the annular member 52 and adapted to extend radially outward from the support structure 6. In some embodiments, the arms 10 are movably coupled to the support structure such that they can transition from a collapsed position to an extended position. The annular member 52 and the respective arms 10, together with an annular inflow ring 20 facilitate anchoring of the prosthetic valve 2 at the desired implantation site. According to some embodiments, the annular inflow ring 20 is dimensioned to secure the valve prosthesis against a proximal surface of the valve annulus. According to some embodiments, the prosthetic valve 2 includes a seal located at or near the proximal end to prevent perivalvular leakage. Such a seal is disclosed, for example, in <patcit id="pcit0002" dnum="EP2047824A"><text>EP-A-2 047 824</text></patcit>..</p><p id="p0018" num="0018">In some embodiments, as discussed in further detail below, the anchoring structure 6 can include a plurality of anchoring arms 10 made at least<!-- EPO <DP n="6"> --> partially of shape-memory material (e.g., Nitinol), which enable regulation of the anchoring and support through the control of the memory of the shape-memory material (e.g., by controlling its temperature). According to other embodiments, the entire anchoring structure 6 is made from a shape memory material. In still other embodiments, the anchoring structure 6 can be made of a re-absorbable material, whereas the valve sleeve 22 can be constituted by biological and/or synthetic tissues, which are in part colonizable or re-absorbable.</p><p id="p0019" num="0019">During implantation, the prosthetic valve 2 is advanced towards the implantation site in a radially contracted configuration, with the annular member 52 in a radially collapsed configuration. According to some embodiments, the annular member 52 has a collapsed diameter of about 5 to about 15 mm in the collapsed configuration. Upon delivery to the target implantation site, expansion of the annular member 52 is facilitated until it reaches an expanded configuration. According to some embodiments, the diameter of the annular member 52 ranges from about 18 mm to about 30 mm in the expanded configuration.</p><p id="p0020" num="0020">According to some embodiments, the annular member 52 has an open mesh structure similar to the structure of a stent used for angioplasty. The mesh structure facilitates expansion of the annular member 52 from a collapsed configuration to an expanded configuration similar to the movement of expansion in situ of an angioplasty stent. According to some embodiments, the annular member 52 has a rhomboidal-mesh structure. In other embodiments, the annular member 52 can be fabricated to have any mesh structure configured to radially expand and collapse in the manner described above.</p><p id="p0021" num="0021">According to some embodiments, the annular member 52 is at least slightly flared outward like an enlarged opening of the flow duct of the blood. This configuration may facilitate positive anchorage of the annular member 52 at the implantation site. In other embodiments, the annular member 52 flares or curves inwardly, such as is described for example in <patcit id="pcit0003" dnum="EP2119417A"><text>EP-A-2 119 417</text></patcit>. Securely anchoring the prosthetic valve 2 at the implantation site promotes perivalvar tightness, improving the hemodynamics and adapting the lines of blood flow in the ventricular chamber to the flow tube constituted by the valve sleeve.<!-- EPO <DP n="7"> --></p><p id="p0022" num="0022">As best shown in <figref idrefs="f0002">FIG. 3</figref>, a plurality of vertical support members 54 are coupled at their proximal ends to the annular member 52. The vertical support members 54 are configured to support the valve sleeve 22 on the anchoring structure 6. According to some embodiments, the support members 54 include generally flat bars set at an angular distance apart from one another by about 120°. In some embodiments, each of the generally flat bars forming the support member 54 include a plurality of apertures or holes formed therein. As shown in <figref idrefs="f0002">FIG. 3</figref>, each of the pleat formations 32 embraces one of the support members 54, with the valve leaflets 24a, 24b and 24c extending in a festoon between two adjacent support members 54. The generally apertured structure of the support members 54 enables the valve sleeve 22 to be secured to the support structure 6 by, for example, suturing stitches according to techniques known to those of skill in the art. In the case where flaps of polymeric materials are used, the flaps can be formed directly on the structure, using techniques such as, for example, dip casting.</p><p id="p0023" num="0023">Also coupled to the annular member 52 are a plurality of anchoring arms 10. As shown in <figref idrefs="f0001 f0002">FIGS. 1-4</figref>, each of the arms 10 includes first and second legs 60, 62 each having a proximal end 64 and a generally U-shaped portion 66 coupled to and bridging between the first and second legs 60, 62. The arms 10, in one embodiment, are coupled to the annular member 52 such that they are disposed over (e.g., centered with respect to) each of the support members 54. As shown in <figref idrefs="f0001">FIG. 1</figref>, according to various embodiments, the prosthetic valve 2 is sized and shaped such that the annular member 52 is located at or near a distal-most portion of the valve. In this embodiment, the prosthetic valve 2 has a length such that once implanted at an appropriate site, the annular member 52 is positioned distal to the valve sinus (VS), while the annular inflow member 20 is located at or near the native valve annulus 16. According to various embodiments, the anchoring arms 10 extend radially outward a sufficient distance to allow a native, stenotic valve leaflet to fit between the arm 10 and the corresponding portion of the body of the anchoring structure 6. As shown, the<!-- EPO <DP n="8"> --> arms 10 also extend from the outflow ring 21 at the distal end of the valve towards the inflow ring 20 at the proximal end of the valve.</p><p id="p0024" num="0024">Additionally, according to some embodiments, each of the arms 10 is movably coupled to the annular member 52 such that they are able to transition from a collapsed position suitable for implantation to an extended position. In the extended position, the arms 10 are configured to anchor and secure the prosthesis at an implantation site. In some embodiments, as shown for example in <figref idrefs="f0001">FIG. 1</figref>, the arms 10 extend proximally a sufficient length to engage the base of the valve sinus (VS), generally at or near the intersection of the valve sinus and the native valve leaflets 19. In this configuration, any force applied to the distal end of the prosthetic valve 2 is transferred by the arms 10 to the base of the valve sinus. The arms 10, thus operate to generally secure the prosthetic valve 2 at the implantation site adjacent the valve annulus and prevent undesired movement or migration of the valve.</p><p id="p0025" num="0025">According to some embodiments, as shown in <figref idrefs="f0002">FIG. 3</figref>, the first and second legs 60, 62 of each arm 10 are made in the form of struts that extend in a generally sinusoidal fashion, with bends or open loops situated on either side with respect to an imaginary line extending approximately in the direction of the overall cylindrical shape of the prosthesis 2. In other embodiments, the sinusoidal pattern can be obtained with bends or open loops that extend from one side and from the other with respect to a line that extends in a circumferential direction with respect to the prosthesis. In another embodiment, the first and second legs may have a mesh structure extending there between. According to some embodiments, the legs 60 include a bends or loops angled away from corresponding bends or loops on the legs 62, to provide additional anchoring within the Valsalva sinus. The bends or loops, for example, may include a curvature adapted to generally match the corresponding portion of the interior wall of the Valsalva sinus. While the embodiments shown in <figref idrefs="f0001 f0002">FIGS. 2-4</figref> have three arms 10, the present invention contemplates embodiments having more or fewer arms 10. In one embodiment, for example, the anchoring structure 6<!-- EPO <DP n="9"> --> includes six arms 10, two arms associated with each of the three Valsalva sinuses.</p><p id="p0026" num="0026">The U-shaped portion 66 extends between and bridges the first and second legs 60, 62 of each arm 10. According to some embodiments, the U-shaped portion 66 is integrally formed with each of the legs 60, 62. According to other embodiments, the U-shaped portion 66 is a separate piece welded to or otherwise attached to each of the legs 60, 62 such that it extends between and forms a bridge between each of the legs 60, 62. According to some embodiments, the length of the U-shaped portion 66 is selected such that the legs 60, 62 are configured to press against and inwardly angled surface of the inner wall of the Valsalva sinus, such that anchoring is improved.</p><p id="p0027" num="0027">The U-shaped portion 66 may be substantially straight, arched, or otherwise bent at the portion extending between the first and second legs 60, 62. The U-shaped portion 66 is generally smooth and free from rough edges such that when it contacts and presses up against tissue at the implantation site it will not cause trauma at the site. According to some embodiments, the U-shaped portion 66 has a curved shape configured to generally match the contours of the base of the valve sinus. Additionally, the U-shaped portion 66 may include a sleeve or other protective coating. The sleeve or protective coating may be formed from a biocompatible polymer or polymeric coating. According to further embodiments the sleeve or protective coating may include a therapeutic agent, such as a steroid, to reduce inflammation at the implantation site.</p><p id="p0028" num="0028">According to some embodiments, as shown for example in <figref idrefs="f0001">FIG. 1</figref>, the anchoring arms 10 have an arched or curved configuration, such that the arms 10 generally follow the longitudinal contours of the patient's valve sinus wall (i.e., from the start of the valve sinus near the valve annulus extending distally away from the valve annulus to the end of the sinus at the vessel wall). In these embodiments, the anchoring arms 10 substantially conform to or engage the sinus walls so as to ensure firm anchorage in situ of the prosthetic valve 2. Examples of arms or support struts configured to substantially engage the sinus walls are shown in <patcit id="pcit0004" dnum="EP1570809A"><text>EP-A-1 570 809</text></patcit> and <patcit id="pcit0005" dnum="EP1690515A"><text>EP-A-1 690 515</text></patcit>.<!-- EPO <DP n="10"> --></p><p id="p0029" num="0029">According to the embodiment shown in <figref idrefs="f0001">FIGS. 1</figref> and <figref idrefs="f0002">3</figref>, the legs 60, 62 of the U-shaped portion 66 define a double curvature. The first curve, which is convex with respect to a longitudinal centerline of the valve 2, extends outwardly away from the outflow ring 21 of the anchoring structure 6. This first curve has a radius of curvature, R1, selected such that the legs 60, 62 generally conform to the curvature at the distal portion of the Valsalva sinus. The second curve, which is concave with respect to a longitudinal centerline of the valve 2, has a radius of curvature, R2, selected such that the legs 60, 62 generally conform to the curvature of the proximal portion of the Valsalva sinus.</p><p id="p0030" num="0030">As will be appreciated by those skilled in the art, the aortic root of the normal heart includes three aortic sinuses, which are distributed in an approximately angularly uniform way around the root of the artery distal to the semi-lunar valve (i.e., the aortic or pulmonary valve). According to various embodiments, as illustrated in <figref idrefs="f0001 f0002">FIGS. 2-3</figref>, the anchoring structure 6 includes three arms 10 set at an angular distance apart of about 120° with respect to a longitudinal axis of the prosthetic valve 2. According to other embodiments, the prosthetic valve 2 includes more or fewer anchoring arms 10 to match human anatomies includes more or fewer aortic sinuses.</p><p id="p0031" num="0031">According to various embodiments, the anchoring arms 10 are shaped such that, in the expanded configuration, the arms 10 apply an outwardly directed radial force against an inner wall of the Valsalva sinus. In some embodiments, the arms 10 are configured such that this radial force is selected to sufficiently anchor that prosthetic valve 10 at the Valsalva sinus under operating conditions typically present during the human cardiac cycle.</p><p id="p0032" num="0032"><figref idrefs="f0002">FIG. 4</figref> is a top cross-sectional view of a prosthetic valve 100 implanted at a native aortic valve site, according to an embodiment of the invention. As shown, and as discussed in detail above, the prosthetic valve 100 can be implanted such that the annular member 152 of the anchoring structure occupies a position distal to the Valsalva sinuses (VS). According to various embodiments, the arms 110 can be arranged and positioned relative to the sinuses of Valsalva such that each of the arms 110 projects into the respective<!-- EPO <DP n="11"> --> sinus of Valsalva and substantially engages the sinus wall. More particularly, as discussed above, the arms 110 project into the Valsalva sinus and rest in a space defined between an open valve leaflet and the sinus wall. As shown in <figref idrefs="f0002">FIG. 4</figref>, each of the arms 110 can be positioned on opposite sides of the coronary ostia (CO) in the respective sinuses of Valsalva. The valve leaflets 24a, 24b, 24c can be positioned within the lumen for blood flow formed by the annular member 152 with the support members (not visible) extending into the lumen by a minimal amount. Upon implantation, the arms 110 of the anchoring structure engage or bear against the walls of the valve sinus at the implantation site, without interfering with the blood flow.</p><p id="p0033" num="0033"><figref idrefs="f0003">FIG. 5</figref> is a flow chart 200 of a method of implanting an expandable heart valve prosthesis according to an embodiment of the present invention. First, a valve prosthesis including an anchoring structure, is transitioned from an expanded position to a collapsed position adapted for delivery of the prosthesis to an implantation site within a patient's heart (block 210). In various embodiments, the prosthesis is delivered using any of a variety of known minimally-invasive delivery techniques. According to one embodiment, the valve is delivered using an off-pump or beating heart procedure. In some embodiments, a crimping tool or other similar device known to those of skill in the art, can be used to radially collapse the prosthetic heart valve including the anchoring structure. One such crimping system, for example, is disclosed in <patcit id="pcit0006" dnum="EP2014257A"><text>EP-A-2 014 257</text></patcit>. After the prosthesis has been transitioned from an expanded position to a collapsed position, the prosthesis can be loaded into a delivery catheter. The prosthesis, according to various embodiments, is delivered using a valve delivery system of the type disclosed in <patcit id="pcit0007" dnum="EP2033581A"><text>EP-A-2 033 581</text></patcit>and/or <patcit id="pcit0008" dnum="EP2033597A"><text>EP-A-2 033 597</text></patcit>.</p><p id="p0034" num="0034">The prosthesis is then delivered to a target implantation site within a patient's heart using known methods and techniques in a minimally invasive manner (block 220). According to some embodiments, the delivery catheter is withdrawn facilitating the automatic expansion of the prosthesis including the support structure from its collapsed configuration to its expanded configuration<!-- EPO <DP n="12"> --> (block 230). According to further embodiments, an inflatable balloon can be inserted and expanded within the prosthetic heart valve facilitating expansion of the valve and the support structure.</p><p id="p0035" num="0035">Once expanded, an annular outflow ring of the prosthetic valve is located generally distal with respect to the valve sinus, and an annular inflow ring is located generally at or near the native valve annulus. In embodiments where the arms are fabricated of a resilient, shape memory material, the arms automatically expand into position such that they generally engage the walls of the valve sinus. The arms, according to various embodiments, engage a space between a native valve leaflet and a sinus wall such that they anchor and secure the prosthesis at the implantation site. In this configuration, the arms generally resist downward movement in response to the pressure exerted upon the prosthesis, such that the valve remains at the desired implantation site (block 240).</p><p id="p0036" num="0036"><figref idrefs="f0004">FIG. 6</figref> is a schematic view of a delivery system 300 for delivering the prosthetic valve 2 to the desired implant location. As shown in <figref idrefs="f0004">FIG. 6</figref>, the delivery system 300 is being used to introduce the prosthetic valve 2 in the same direction as the blood flow, BF. In other words, as shown in <figref idrefs="f0004">FIG. 6</figref>, the delivery system 300 is being introduced into to the Valsava sinus (VS) region of the aortic valve through the left ventricle. As shown, the delivery system 300 includes a sheath or catheter 302, a first deployment element 304, and a second deployment element 306. The prosthetic valve 2 is shown in its collapsed configuration and is disposed inside the deployment elements 304, 306. As further shown in <figref idrefs="f0004">FIG. 6</figref>, in various exemplary embodiments, the delivery system 300 includes a guidewire or stylet 310 coupled to a centering mechanism 314. The centering mechanism 314 may be used to help center the delivery system 300 in the aorta (AO) during an implantation procedure. During implantation, the delivery system 300 is used to advance the prosthetic valve to the desired implant location, for example, at or near the annulus (A) of the native aortic valve. Once disposed at the desired location, the implanting physician may activate the deployment elements 304, 306, by causing one or both to move back or forth<!-- EPO <DP n="13"> --> with respect to the prosthetic valve 2, which thereby releases the valve and allows is to expand radially and contact the wall of the annulus, aorta, and/or valve sinus. According to other embodiments, other delivery systems may be used to implant the prosthetic valve 2. Exemplary delivery systems are disclosed in <patcit id="pcit0009" dnum="EP1935378A"><text>EP-A-1 935 378</text></patcit> and <patcit id="pcit0010" dnum="EP1935377A"><text>EP-A-1 935 377</text></patcit>.</p><p id="p0037" num="0037">Various modifications and additions can be made to the exemplary embodiments discussed without departing from the scope of the present invention. For example, while the embodiments described above refer to particular features, the scope of this invention also includes embodiments having different combinations of features and embodiments that do not include all of the described features. Accordingly, the scope of the present invention is intended to embrace all such alternatives, modifications, and variations as fall within the scope of the claims, together with all equivalents thereof.</p></description><claims mxw-id="PCLM56982744" lang="EN" load-source="patent-office"><!-- EPO <DP n="14"> --><claim id="c-en-0001" num="0001"><claim-text>A valve prosthesis for implantation in or near a human heart at a valve site, the valve site including one or more valve sinuses, the prosthesis (2) comprising:
<claim-text>an anchoring structure (6) comprising an annular outflow member (21), an annular inflow member (20), and a plurality of arms (10) each coupled at one end to the annular outflow member (21), the arms having a first end coupled to the annular outflow member (21) and a second end configured to contact a base of the valve sinus; and</claim-text>
<claim-text>a plurality of leaflets (24a, 24b, 24c) coupled to the anchoring structure (6) and adapted to substantially allow blood flow in a first direction and to substantially prevent blood flow in a second direction;</claim-text>
<claim-text>wherein the annular outflow member (21) has an expanded position generally configured to engage a vessel wall at a location distal to the valve sinus, and wherein at least one of the plurality of arms (10) is shaped to engage substantially an entire longitudinally extending surface of the valve sinus.</claim-text></claim-text></claim><claim id="c-en-0002" num="0002"><claim-text>The valve prosthesis of claim 1 wherein each of the plurality of arms (10) includes a first leg and a second leg and a U-shaped portion extending between the first and second legs.</claim-text></claim><claim id="c-en-0003" num="0003"><claim-text>The valve prosthesis of claim 1 wherein the arms (10) are configured to secure and stabilize the prosthetic heart valve (2) at an implantation site relative to native heart valve leaflets.<!-- EPO <DP n="15"> --></claim-text></claim><claim id="c-en-0004" num="0004"><claim-text>The valve prosthesis of claim 1 wherein the arms (10) are configured to contact a space defined between an open valve leaflet (24a, 24b, 24c) and the sinus wall.</claim-text></claim><claim id="c-en-0005" num="0005"><claim-text>The valve prosthesis of claim 1 wherein the arms (10) comprise a shape memory material.</claim-text></claim><claim id="c-en-0006" num="0006"><claim-text>The valve prosthesis of claim 1 wherein the anchoring structure (6) comprises a shape memory material.</claim-text></claim><claim id="c-en-0007" num="0007"><claim-text>The valve prosthesis of claim 1 wherein the arms (10) and said expandable stent structure are dimensioned so that a native, stenotic heart valve leaflet can fit therebetween.</claim-text></claim><claim id="c-en-0008" num="0008"><claim-text>The valve prosthesis of claim 1 wherein the annular inflow member (20) is dimensioned to secure the valve prosthesis (2) against a proximal surface of the valve annulus.</claim-text></claim><claim id="c-en-0009" num="0009"><claim-text>A valve prosthesis comprising an plurality of valve leaflets (24a, 24b, 24c) coupled to an anchoring structure (6), the anchoring structure including one or more anchoring arms (10) adapted to substantially engage a valve sinus, the anchoring arms (10) including a free end adapted to contact a base of the valve sinus adjacent one or more native valve leaflets.</claim-text></claim><claim id="c-en-0010" num="0010"><claim-text>The valve prosthesis of claim 9 further comprising a seal disposed between a proximal end of the anchoring structure (6) and a native valve leaflet.</claim-text></claim><claim id="c-en-0011" num="0011"><claim-text>A kit for implanting a heart valve prosthesis at an implantation site within a patient's heart, the kit comprising:
<claim-text>an expandable heart valve prosthesis including an expandable prosthetic heart valve (2) having three leaflets (24a, 24b, 24c)<!-- EPO <DP n="16"> --> coupled to an anchoring structure (6), the anchoring structure including an annular outflow member (21) and a plurality of arms (10) movably coupled to the annular member, wherein the arms (10) are configured to contact a base of a valve sinus adjacent an open native heart valve leaflet;</claim-text>
<claim-text>a crimping tool adapted to transition (220) the prosthesis from an expanded position to a collapsed position; and</claim-text>
<claim-text>a delivery catheter (302) adapted to deliver the prosthesis to the implantation site.</claim-text></claim-text></claim><claim id="c-en-0012" num="0012"><claim-text>The kit of claim 11 further comprising an inflatable balloon (304, 306) adapted to transition the prosthesis from the collapsed position to the expanded position at the implantation site.</claim-text></claim><claim id="c-en-0013" num="0013"><claim-text>The kit of claim 11 in which fingers and said expandable stent structure are dimensioned so that a native, stenotic heart valve leaflet can fit therebetween.</claim-text></claim></claims><drawings mxw-id="PDW16671082" load-source="patent-office"><!-- EPO <DP n="17"> --><figure id="f0001" num="1,2"><img id="if0001" file="imgf0001.tif" wi="151" he="209" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="18"> --><figure id="f0002" num="3,4"><img id="if0002" file="imgf0002.tif" wi="137" he="224" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="19"> --><figure id="f0003" num="5"><img id="if0003" file="imgf0003.tif" wi="126" he="157" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="20"> --><figure id="f0004" num="6"><img id="if0004" file="imgf0004.tif" wi="66" he="140" img-content="drawing" img-format="tif"/></figure></drawings><search-report-data><doc-page id="srep0001" file="srep0001.tif" wi="159" he="233" type="tif"/><doc-page id="srep0002" file="srep0002.tif" wi="159" he="233" type="tif"/></search-report-data><copyright>User acknowledges that Fairview Research LLC and its third party providers retain all right, title and interest in and to this xml under applicable copyright laws.  User acquires no ownership rights to this xml including but not limited to its format.  User hereby accepts the terms and conditions of the Licence Agreement</copyright></patent-document>
